Craniomaxillofacial Implants Market Expected to Reach USD 1.75 Billion Globally in 2022

The Global craniomaxillofacial implants market was valued at USD 1,010.0 million in 2013 and is projected to expand at a CAGR of 6.2% from 2014 to 2022 to reach USD 1,752.9 million in 2022.

 

Craniomaxillofacial surgery refers to a procedure used for the treatment of severely injured cranial or facial bones. Treatment of such deformities in the maxillofacial region mostly requires internal fixation devices such as plate and screw fixation systems, distraction systems, and bone graft substitutes to fix the facial fractures. Various factors such as increasing incidence of road accidents leading to facial trauma, coupled with emergence of new procedural techniques have fueled the growth of the global craniomaxillofacial implants market. In addition, introduction of bioresorbable implants would boost the growth of the global craniomaxillofacial implants market during the forecast period from 2014 to 2022. 

 

Based on location, the internal fixators segment accounted for the largest share (over 80%) of the craniomaxillofacial implants market in 2013, as these devices demonstrated lesser infection rates augmenting procedure safety and shorter hospital stays. The internal fixators market segment is also anticipated to grow at the highest CAGR from 2014 to 2020. Technological breakthroughs with regard to internal fixators and greater reliability of these implants are the major factors attributed to the high growth of the internal fixators segment.

 

Based on composition, the metals and alloys segment held the largest share of the market in 2013 due to excellent biocompatibility and better osseointegration properties. Moreover, metals and alloys such as titanium and cobalt-chromium are not susceptible to corrosion, hence eliminating the need for a second surgical intervention. However, the biologic materials segment is anticipated to expand at the fastest CAGR during the forecast period. Factors such as flexible and non-toxic nature of the craniomaxillofacial implants made from biologic material is contributing to the high growth of the segment. 

 

Get Sample Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=4861

 

Based on nature, the non-resorbable fixators segment accounted for the largest share of the global craniomaxillofacial implants market. Non-resorbable implants have better mechanical properties and are comparatively cheaper and easily available. However, the resorbable fixators segment is expected to expand at the highest CAGR due to high reabsorption power in approximately 12 months and greater biocompatibility. In addition, eliminating the need for undergoing a second surgery in case of resorbable fixators would boost the growth of the segment in the near future. 

 

Based on type of product, the plate and screw fixator systems segment held the largest share of the global craniomaxillofacial implants market. Availability of a range of plates and screws based on varying anatomical regions and better stabilization of deformed cranial and facial bones is driving the growth of the plate and screw fixator systems segment. On the other hand, the distraction systems segment is estimated to grow rapidly during the forecast period due to increase in jaw distortion cases in road accidents and high standards of the distraction technique results. Moreover, distraction systems can efficiently correct genetic deformities in the jaws, thus contributing to the growth of the segment. 

 

In terms of regional market analysis, North America accounted for the largest share (over 50%) of the global craniomaxillofacial implants market in 2013 as the region has always been on the leading edge of medical device technology and adoption. Availability of technologically advanced craniomaxillofacial implants and increasing awareness of the population pertaining to internal and external fixation of cranial bones is boosting the growth of the craniomaxillofacial implants market in North America. Similarly, countries in Asia Pacific such as Japan, South Korea, Australia, Malaysia, India, and China are witnessing remarkable growth. Large population suffering from genetic facial abnormalities, easy market penetration in developing economies, and favorable support from governments for the improvement of health care infrastructure would boost the growth of the craniomaxillofacial implants market in Asia Pacific. This is likely to contribute to the growth of the market in the region during the forecast period from 2014 to 2022. Moreover, increasing initiatives by governments and welfare associations to spread awareness about the safety and efficacy of craniomaxillofacial implants would trigger the growth of the craniomaxillofacial implants market in Asia Pacific.